Your browser does not support JavaScript!
Logo de Labiotech.eu

Labiotech.eu Source d'actualité

Une actualité de Labiotech.eu a été ajouté(e)
Il y a 3 jours
Recent advancements in prostate cancer research over the past year
Prostate cancer is the second most commonly occurring cancer in men. More than 1.4 million people were diagnosed with prostate cancer in 2020, according to the World Cancer Research Fund...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours
The next frontier in genomic technologies for rare diseases
By Neil Ward, VP and General Manager at PacBio EMEA It’s been 40 years since the passage of the Orphan Drug Act, which catalyzed the development of hundreds of therapies for rare diseases, with more...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 5 jours
Five biotech companies taking Los Angeles by storm
Known throughout history for being home to the iconic scene of Hollywood, in recent years Los Angeles has also become a thriving biotech hub, after years of playing second fiddle in the U.S. to the...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 6 jours
Rebuilding relations: U.K. rejoins Horizon Europe to boost funding opportunities
The U.K. is rejoining the European Union’s (EU’s) $100 billion research program Horizon Europe, after being locked out of the deal amid post Brexit tensions for more than two years. This comes after...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine
Five latest advancements in NASH research
Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD) – a condition where fat builds up in the liver, potentially causing liver damage or cirrhosis....
www.labiotech.eu
Charger plus d'actualités

Informations juridiques
SIREN / SIRET - DE Labiotech

Adresse
Berlin Berlin DE Allemagne